Foghorn Therapeutics (FHTX) Selling, General & Administrative (2019 - 2026)
Powered by 
Analysis
Foghorn Therapeutics (FHTX) Selling, General & Administrative (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | 582.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | 662.10 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | -417.00 Mn |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | 216.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 110.21 Mn |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 593.21 Mn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 347.92 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 161.89 Mn |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 247.47 Mn |
| 10 | Foghorn Therapeutics | 346.08 Mn | 278.00 Mn | - | 6.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.35 Mn |
| Mar 31, 2026 | 6.58 Mn |
| Dec 31, 2025 | 6.80 Mn |
| Sep 30, 2025 | 6.65 Mn |
| Jun 30, 2025 | 6.86 Mn |
| Mar 31, 2025 | 7.24 Mn |
| Dec 31, 2024 | 6.35 Mn |
| Sep 30, 2024 | 6.97 Mn |
| Jun 30, 2024 | 7.33 Mn |
| Mar 31, 2024 | 7.71 Mn |
| Dec 31, 2023 | 7.02 Mn |
| Sep 30, 2023 | 8.31 Mn |
| Jun 30, 2023 | 8.40 Mn |
| Mar 31, 2023 | 8.64 Mn |
| Dec 31, 2022 | 7.86 Mn |
| Sep 30, 2022 | 7.97 Mn |
| Jun 30, 2022 | 7.70 Mn |
| Mar 31, 2022 | 7.22 Mn |
| Dec 31, 2021 | 6.33 Mn |
| Sep 30, 2021 | 5.81 Mn |